A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients

Trial Profile

A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Vismodegib (Primary) ; Antineoplastics
  • Indications Basal cell cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RegiSONIC
  • Sponsors Genentech
  • Most Recent Events

    • 25 Jul 2017 Status changed from active, no longer recruiting to discontinued.
    • 08 Mar 2016 Results of a preliminary sub-group analysis (n=88) presented at the 74th Annual Meeting of the American Academy of Dermatology
    • 20 May 2015 According to Curis media release, data from this and other two trials ( see profile 209178 and 200209) will be presented at the Annual Meeting of American Society of Clinical Oncology (ASCO).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top